The present results of our analysis in the liver indicate a site-dependent NLRP3 inflammasome regulation throughout obesity, since overexpression of NLRP3, CASP1 (p20), and IL-18 (p18) took place only at 16 week of DIO. The gene discussed is NLRP3; the disease is obesity disorder.